Added to YB: 2026-07-15
Pitch date: 2026-07-12
DXRX.L [neutral]
Diaceutics PLC
-1.05%
current return
Author Info
Quality Stocks helps you find valuable insights to become a better investor, discover quality companies, and find investment ideas. Sign up for the newsletter.
Company Info
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
Market Cap
GBP 120.2M
Pitch Price
GBP 1.43
Price Target
N/A
Dividend
N/A
EV/EBITDA
26.06
P/E
1.3K
EV/Sales
2.97
Sector
Life Sciences Tools and Services
Category
growth
My 12 Picks for 2026, Q1 Performance Review - Diaceutics PLC
DXRX.L (update): Medical data/diagnostics platform. FY26 absolute profitability tracking slightly below initial projections but core top-line growth robust. Expanding commercial market penetration + rolling out higher-value data/diagnostic services. Margin compression seen as natural byproduct of scaling; footprint validates long-term compounding thesis.
Read full article (1 min)